Unlock stock picks and a broker-level newsfeed that powers Wall Street.

KOSDAQ - Delayed Quote KRW

J2KBIO Co., Ltd. (420570.KQ)

11,730.00
+600.00
+(5.39%)
At close: April 30 at 3:30:30 PM GMT+9
Loading Chart for 420570.KQ
  • Previous Close 11,130.00
  • Open 11,340.00
  • Bid 11,700.00 x --
  • Ask 11,740.00 x --
  • Day's Range 11,000.00 - 12,140.00
  • 52 Week Range 7,940.00 - 41,250.00
  • Volume 189,608
  • Avg. Volume 334,726
  • Market Cap (intraday) 67.024B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date --
  • Forward Dividend & Yield 200.00 (1.71%)
  • Ex-Dividend Date Dec 27, 2024
  • 1y Target Est --

J2KBIO Co., Ltd., a bio venture company, provides active ingredients for cosmetics, functional food, and household products from natural materials and microbial fermentation. The company was founded in 2014 and is based in Cheongju, South Korea.

www.j2kbio.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 420570.KQ

View More

Performance Overview: 420570.KQ

Trailing total returns as of 4/30/2025, which may include dividends or other distributions. Benchmark is KOSPI Composite Index (^KS11) .

YTD Return

420570.KQ
28.90%
KOSPI Composite Index (^KS11)
6.55%

1-Year Return

420570.KQ
35.09%
KOSPI Composite Index (^KS11)
5.03%

3-Year Return

420570.KQ
64.29%
KOSPI Composite Index (^KS11)
5.14%

5-Year Return

420570.KQ
64.29%
KOSPI Composite Index (^KS11)
31.27%

Compare To: 420570.KQ

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 420570.KQ

View More

Valuation Measures

Annual
As of 4/30/2025
  • Market Cap

    67.02B

  • Enterprise Value

    56.06B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.96

  • Price/Book (mrq)

    2.14

  • Enterprise Value/Revenue

    1.69

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -4.99%

  • Return on Assets (ttm)

    7.82%

  • Return on Equity (ttm)

    -6.80%

  • Revenue (ttm)

    33.13B

  • Net Income Avi to Common (ttm)

    -1.65B

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    13.05B

  • Total Debt/Equity (mrq)

    6.66%

  • Levered Free Cash Flow (ttm)

    -1.62B

Research Analysis: 420570.KQ

View More

Company Insights: 420570.KQ

Research Reports: 420570.KQ

View More
Waiting for permission
Allow microphone access to enable voice search

Try again.